Literature DB >> 2989101

IS50-mediated inverse transposition: specificity and precision.

D K Nag, U DasGupta, G Adelt, D E Berg.   

Abstract

The IS50 elements, which are present as inverted repeats in the kanamycin-resistance transposon, Tn5, can move in unison carrying with them any interstitial DNA segment. In consequence, DNA molecules such as a lambda::Tn5 phage genome are composed of two overlapping transposons - the kan segment bracketed by IS50 elements (Tn5), and lambda bracketed by IS50 elements. During direct transposition, mediated by IS50 "O" (outside) ends, the kan gene is moved and the lambda vector is left behind. During inverse transposition, mediated by the "I" (inside) ends of the IS50 elements, the lambda vector segment is moved and the kan gene is left behind. Direct transposition is several orders of magnitude more frequent than inverse transposition (Isberg and Syvanen, 1981; Sasakawa and Berg, 1982). We assessed the specificity and precision of the rare events mediated by pairs of I ends by mapping and sequencing independent inverse transpositions from a lambda::Tn5 phage into the amp and tet genes of plasmid pBR322. Using restriction analyses, 32 and 40 distinct sites of insertion were found among 46 and 72 independent inverse transpositions into the amp and tet genes, respectively. Eleven sites were used in two or more insertion events, and the two sites in tet used most frequently corresponded to major hotspots for the insertion of the Tn5 (by direct transposition). The sequences of 22 sites of inverse transposition (including each of the sites used more than once) were determined, in eleven cases by analyzing both pBR322-IS50 junctions, and in eleven others by sequencing one junction. The sequence of the "I" end of IS50 was preserved and 9-bp target sequence duplications were present in every case analyzed. GC pairs were found at each end of the target sequence duplication in ten of the eleven sites used more than once, and also in seven of the other eleven sites. Our data indicate that transposition mediated by pairs of "I" ends is similar in its specificity and precision to the more frequent transposition mediated by IS50 "O" ends.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989101     DOI: 10.1016/0378-1119(85)90290-2

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  9 in total

1.  Deletions in plasmid pBR322: replication slippage involving leading and lagging strands.

Authors:  K Weston-Hafer; D E Berg
Journal:  Genetics       Date:  1991-04       Impact factor: 4.562

2.  Palindromy and the location of deletion endpoints in Escherichia coli.

Authors:  K Weston-Hafer; D E Berg
Journal:  Genetics       Date:  1989-04       Impact factor: 4.562

3.  Limits to the role of palindromy in deletion formation.

Authors:  K Weston-Hafer; D E Berg
Journal:  J Bacteriol       Date:  1991-01       Impact factor: 3.490

4.  Simple and efficient generation in vitro of nested deletions and inversions: Tn5 intramolecular transposition.

Authors:  D York; K Welch; I Y Goryshin; W S Reznikoff
Journal:  Nucleic Acids Res       Date:  1998-04-15       Impact factor: 16.971

5.  DNA binding and phasing analyses of Tn5 transposase and a monomeric variant.

Authors:  D York; W S Reznikoff
Journal:  Nucleic Acids Res       Date:  1997-06-01       Impact factor: 16.971

6.  Gene organization and target specificity of the prokaryotic mobile genetic element IS26.

Authors:  B Mollet; S Iida; W Arber
Journal:  Mol Gen Genet       Date:  1985

7.  Specificity of bacteriophage Mu excision.

Authors:  D K Nag; D E Berg
Journal:  Mol Gen Genet       Date:  1987-05

8.  Tn5 insertion specificity is not influenced by IS50 end sequences in target DNA.

Authors:  J K Lodge; K Weston-Hafer; D E Berg
Journal:  Mol Gen Genet       Date:  1991-08

9.  Target site choice of the related transposable elements Tc1 and Tc3 of Caenorhabditis elegans.

Authors:  H G van Luenen; R H Plasterk
Journal:  Nucleic Acids Res       Date:  1994-02-11       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.